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Abstract.  The 20-kD regulatory light chain (RLC) 
plays a central role in the regulation of smooth muscle 
contraction. Little is known about the structure or ex- 
pression of smooth muscle myosin light chain (MLC) 
genes. A  cDNA library was constructed in the expres- 
sion vector, Lgt-ll, with mRNA derived from cultured 
rat aortic smooth muscle cells.  Using antibody gener- 
ated against tracheal smooth muscle myosin, three 
cDNA clones encoding a  RLC were isolated, one of 
which, SmRLC-2, represents a full-length transcript of 
the RLC mRNA.  The derived amino acid sequence 
shows 94.2%  homology with the chicken gizzard 
RLC, and 70 and 52%  homology with the rat skeletal 
and cardiac muscle MLC-2 proteins, respectively. 
Thus, the gene encoding the putative smooth muscle 
RLC appears to have originated by duplication of the 
same ancestor that gave rise to the sarcomeric MLC-2 
genes. Contrary to the stringent tissue-specific expres- 
sion of sarcomeric MLC-2 genes, RNA blot hybridiza- 
tion and S1  nuclease mapping demonstrates that the 
putative smooth muscle RLC gene is expressed in 
smooth, sarcomeric, and nonmuscle tissues at sig- 
nificant levels. Primer extension analysis suggests that 
the same promoter region is used in these different tis- 
sues.  Thus the putative smooth muscle RLC gene ap- 
pears to be a  gene that is constitutively expressed in a 
large variety of cells and has a  differentiated function 
in smooth muscle. 
T 
HE contractile elements of smooth muscle are arranged 
in a unique pattern of filaments dispersed throughout 
the cytoplasm (for a review, see 10). Myosin is a major 
component of these filaments and is comprised of two identi- 
cal 200-kD heavy chains and two sets of light chains of 20 
and 17 kD (for a review,  see 22). The 20 kD, or regulatory 
light chain (RLC),I plays a central role in the regulation of 
smooth muscle contraction (for a  review,  see  1,  23).  The 
RLC is phosphorylated on a specific serine (serine 19) (31) 
by the enzyme myosin light chain (MLC) kinase in the pres- 
ence of calcium and calmodulin. This phosphorylation is 
responsible for the increase in actin-activated Mg ATPase ac- 
tivity of smooth muscle myosin (9, 49, 51). A strong correla- 
tion has been found between RLC phosphorylation and the 
initiation of muscle contraction in a number of smooth mus- 
cle tissues (3,  16, 24, 50). RLC phosphorylation causes the 
unfolding of smooth and nonmuscle myosin and regulates the 
assembly of  these myosins into filaments in vitro (14, 48, 53). 
RLC phosphorylation also appears to affect the interaction 
of actin and myosin by regulating the movement of smooth 
muscle myosin on actin filaments (47). Recently, it has been 
shown that MLC kinase also phosphorylates the RLC at 
1. Abbreviations used in this paper: MLC, myosin light chain; RASM, rat 
aortic smooth muscle and; RLC, regulatory light chain. 
threonine  18  (25).  This  second phosphorylation also  in- 
creases the actin-activated ATPase activity. In addition, the 
RLC is phosphorylated at other sites by a  number of en- 
zymes including epidermal growth factor (21) and protein ki- 
nase C  (38).  The consequences of these phosphorylations 
are not well understood. 
Both skeletal and cardiac muscle also contain phosphory- 
latable RLCs. These RLCs have amino acid compositions 
flanking the phosphorylated serine residue similar to that of 
the smooth muscle RLC (42).  However, phosphorylation of 
the serine does not result in the dramatic changes in ATPase 
activity and does not appear to be necessary for skeletal or 
cardiac muscle contraction (see 1). Thus, the RLC appears 
to play a unique role in smooth muscle. It would be expected 
that this role is at least partially determined by the primary 
structure of the smooth muscle RLC. In addition, the regula- 
tion of smooth muscle RLC gene(s) expression might play 
an important role in regulating smooth muscle contraction. 
There  is  limited  information  concerning  the  primary 
structure of the smooth muscle RLC. Maita et al. reported 
the sequence of the chicken gizzard RLC derived from se- 
quencing tryptic peptides (31). Pearson et al. (42) assigned 
a different arrangement of tryptic peptides comprising the 
first 20 amino acids of the amino terminus of the chicken giz- 
zard RLC. Although RLC genes have been isolated for both 
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RLC gene(s) has yet to be characterized. 
To better understand the structure of the smooth muscle 
RLC, to allow for comparisons between skeletal,  cardiac, 
and smooth muscle genes,  and to elucidate the molecular 
mechanisms responsible for smooth muscle RLC gene ex- 
pression, eDNA clones encoding a RLC were isolated from 
a  ~,gt-ll rat aortic smooth muscle (RASM) library. We report 
the characterization of these clones and compare the derived 
amino  acid  sequence of the  coding region with  those re- 
ported for rat cardiac and skeletal muscle. In addition, RNA 
blot hybridization, S1 nuclease mapping, and primer exten- 
sion analyses are presented and demonstrate that the putative 
smooth muscle RLC gene is expressed in smooth, cardiac, 
skeletal, and nonmuscle tissues. 
Materials and Methods 
Reagents 
Restriction endonucleases and DNA-modifying enzymes were purchased 
from New England Biolabs (Beverly, MA), New England Nuclear (Boston, 
MA), and Bethesda Research Laboratories (Gaithersburg, MD). Double- 
stranded M13 sequencing vector Ml3mpl8 was obtained from New England 
Nuclear and the M13 sequencing kit from New England Biolabs. Radioiso- 
topes were purchased from Amersham Corp.  (Arlington Heights, IL). 
Rat Aortic Smooth Muscle (RASM) Cell Culture 
Cultures of vascular smooth muscle cells isolated from rat thoracic aorta 
by enzymatic dissociation (8) were provided by Drs. R. Wayne Alexander 
and Michael A. Gimbrone, Jr.  Cells were grown in DME supplemented 
with 10% heat-inactivated calf serum, 1130 U/ml penicillin, and 100 Izg/ml 
streptomycin and serially passaged upon reaching confluence. Cells in sub- 
culture passage 11  were used to generate RNA for the eDNA library and 
from passages 7-22 for other experiments. 
Isolation of RNA 
Total RNA was extracted from rat tissues by the hot phenol procedure (52). 
Total  cytoplasmic RNA was isolated from confluent cultures of RASM, 
I..6E9 myotubes and myoblasts, or rat 313  fibroblasts as described (4).  To 
eliminate DNA, the RNA was precipitated once with guanidine hydrochlo- 
ride (13) and ethanol. Poly(A  +) RNA was purified from RASM RNA by 
affinity chromatography on oligo(dT)-cellulose (2).  This  fraction repre- 
sented 'x,l% of total cytoplasmic RNA. 
Antiserum Preparation 
The IgG fraction derived from rabbit antiserum made against bovine tra- 
cheal smooth muscle myosin was a generous girl of Dr. Robert Adelstein. 
Before use, the IgG was adsorbed with ~gt-ll-infected Escherichia  coti 
Y1090 lysates on nitrocellulose filters in order to remove antibodies to both 
E.  coli and %gt-ll. A dilution corresponding to  1:1000 of the original IgG 
fraction was used for subsequent screenings. 
Construction of a cDNA Library in ygt-ll 
Double-stranded eDNA was synthesized using 5  lag of RASM poly(A  +) 
RNA as template and 2.4 Izg of oligo-dT(12-18)  as primer following the 
procedures of Okayama and Berg (40). The eDNA was methylated using 
the procedure of Maniatis et al. (33). An equal mass of Eco RI linkers were 
then ligated to the eDNA using "1"4 DNA ligase (0.25  U/ng eDNA) and the 
double-stranded DNA was digested with Eco R/to create cohesive ends. 
The eDNA was separated from excess Eco RI linker monomers by chroma- 
tography on Sepharose CL4B. ~,gt-ll DNA was digested with Eco RI and 
treated with 0.025 U calf intestine alkaline phosphatase (Boehringer Mann- 
helm Diagnostics, Inc., Houston, TX)/l.tg DNA for 1 h. eDNA was ligated 
to kgt-ll arms using the procedure of Dugaiczyk et al. (17). The recombinant 
DNAs were packaged into phage using packaging extracts from Amersham 
Corp. The library contained 2.2  ×  10  ~ members with 33% containing in- 
serts. The library was subsequently amplified at 42°C in E. coli strain Y1088 
(32). 
Screening of the cDNA Library 
The library was screened with anti-myosin antibody and 12~I-labeled pro- 
tein A using procedures described by Young and Davis (61, 62). A single 
positive clone (SmRLC-1) was purified to homogeneity by repeated plating. 
An isolated plaque was picked, amplified, and used for large scale prepara- 
tion of phage (33, 60). The eDNA insert was isolated from the Lgt-ll clone 
by digestion with Eco RI endonuclease followed by electrophoresis on an 
0.8% agarose gel. The insert was then subcloned into M13mpl8 and single 
stranded DNA was prepared (35). The complementary strand was then la- 
beled using the M13 universal primer, [ct-32P] dATP and dCTE and DNA 
polymerase 1 (Klenow fragment). The uniformly labeled insert was then ex- 
cised with Eco RI endonuclease, separated on a 5% acrylamide gel, and 
electroeluted.  Using this  labeled  fragment,  the  eDNA  library  was  re- 
screened by the colony filter hybridization procedure of Benton and Davis 
(5).  Filters were prehybridized in 5  x  SSC (0.15 M NaCI, 0.015 M sodium 
citrate), 0.025 M sodium phosphate, pH 6.5, 0.1% SDS, 50 lag/ml calf thy- 
mus DNA, 10×  Denhardt's solution (15), and 25% formamide at 42°C for 
4 h. Hybridization was overnight at 42°C in the same buffer, but containing 
25%  dextran sulfate and 2×  Denhardt's solution.  The hybridized filters 
were washed repeatedly in 1× SSC, 0.1% SDS at 65°C. The filters were air 
dried and exposed for autoradiography on Kodak X-Omat R  film using 
Picker Max intensifying screens. 
Nucleic Acid Sequence Determination 
DNA sequence determination was performed by the dideoxy-sequencing 
method of Sanger (46) using the commercially available universal M13 pen- 
tadecamer primer (No. 1211; New England Biolabs, Beverly,  MA) to prime 
second-stranded synthesis. Portions of the sequence were confirmed by the 
method of Maxam and Gilbert (34). 
RNA Blot Hybridization 
10 lag of total RNA was size fractionated by electrophoresis on 1% agarose 
gels in 200 mM 4-morpholinepropanesulfonic  acid, pH 7.4,  1 mM EDTA, 
and 3%  formaldehyde. Transfer to nitrocellulose (Schleicher &  Schuell, 
Inc.,  Keene,  NH)  and  hybridization to  nick-translated (43)  32p-labeled 
DNA was as described (55).  At the end of hybridization, the filters were 
washed in 0.1×  SSC, 0.1% SDS at 65°C. 
SI Nuclease Mapping 
Restriction endonuclease digestions were performed under the conditions 
recommended by the suppliers. 
The Rsa I restriction fragment was prepared from SmRLC-6 as follows. 
The SmRLC-6 insert was subcloned into M13mpl8  and the recombinant 
phage restricted with Nco I and Pst I. A 372-bp fragment was separated on 
a 6 % acrylamide gel and electroeluted. After ethanol precipitation, the sam- 
ple was restricted with Rsa I, ethanol precipitated, and then labeled at the 
3' end with [a-32p]cordycepin and terminal transferase (56).  The labeled 
fragment was then purified on an 8% acrylamide gel, strand separated on 
a  5%  acrylamide gel,  and  the strand complementary to  the  RNA  was 
purified (34). 
The Pst I/Nco I fragment was prepared from SmRLC-2 as follows. The 
RLC-2 insert was subcloned into M13mpl8  and the recombinant phage re- 
stricted with Nco I. The Nco I site was labeled on the recessed 3' end with 
[a-32P] dATP using the Klenow fragment of E.  coli  DNA polymerase I 
(32), and then digested with Pst I. The Pst I cleaved in the M13 polylinker 
to yield a 485-bp fragment. This double-stranded fragment, labeled only 
on the strand complementary to the RNA, was purified by electrophoresis 
on a 5 % polyacrylamide gel and boiled for 5 min immediately before hy- 
bridization with RNA. 
S1 nuclease mapping was carried out with 25 lag of RNA using a modi- 
fication of the Berk and Sharp technique (6) as previously described (30). 
Samples were analyzed on 5 (for experiments using the Pst I/Nco I frag- 
ment) or 8%  (Rsa I fragment) polyacrylamide gels. 
Oligonucleotide Synthesis and Primer Extension 
21-mer and 39-mer single-stranded DNA oligonucleotides (Fig. 1 B, under- 
lined regions) were synthesized using the DNA synthesizer according to the 
protocols  recommended by  the  supplier  (model  8600;  Biosearch,  San 
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The primer extension was done as described (7) except that annealing was 
performed using 5 ng of end-labeled primer and 30 I.tg of RNA in 50 mM 
NaCI, 34 mM Tris-HCl, pH 8.3, 6 mM MgCI2,  and 5 mM dithiothreitol 
at 65°C for 15 min and 42°C for 15 min. Extension reactions were per- 
formed using 2.5 mM dGTP,  dTTP, dCTP,  and dATE and 28 U of avian 
myeloblastosis virus reverse transcriptase for 1 h at 42"C. Extended prod- 
ucts were analyzed on 6% polyacrylamide-urea gels. 
Results 
Isolation and Characterization  of 
RASM RLC eDNA Clones 
To isolate eDNA clones encoding the smooth muscle myosin 
RLC, a library was constructed in Lgt-ll from RASM poly- 
(A  ÷) RNA.  5  ×  105 recombinants were screened using IgG 
directed  against  bovine tracheal  myosin.  A  single positive 
clone was purified after three rounds of repeat plating.  This 
clone,  SmRLC-1, proved to have an insert of 234 bp. After 
being excised from igt-ll and subcloned into the Eco RI site 
of M13mpl8,  the  insert  was  sequenced  and  identified  as a 
RLC  (Fig.  1). 2 
The SmRLC-1  insert was labeled with 32p and then used 
to rescreen the RASM  library.  10 additional  eDNA clones 
were detected by positive hybridization to the SmRLC-1  in- 
sert.  Seven clones contained  inserts of 927 bp (SmRLC-2, 
3, 5, 7, 9,  10),  two of 680 bp (SmRLC-6,8),  and one of 234 
bp (SmRLC-4). These inserts were also excised from ~,gt-ll 
and subcloned into M13mpl8. Restriction endonuclease map- 
ping  demonstrated  that  all  clones  were  derived  from  the 
same mRNA and were overlapping (Fig.  1 a). By sequencing 
the inserts from the overlapping clones SmRLC-1, SmRLC- 
2, and SmRLC-6, the complete nucleotide sequence for the 
927-bp insert was obtained. Fig. 1 b shows the nucleotide and 
derived amino acid sequence for the putative smooth muscle 
RLC eDNA. The eDNA contains a 69-nucleotide 5' untrans- 
lated region,  a  516-nucleotide  (172 amino acids) coding re- 
gion, and a  342-nucleotide  3'-untranslated  region ending in 
a  short  17-nucleotide  poly-A tail. 
Fig.  1 c shows a comparison of the derived amino acid se- 
quence  for the RASM  RLC  with published  sequences  de- 
rived from rat skeletal (39) and cardiac (28) muscle MLC-2 
cDN//s and from direct sequencing of tryptic peptides iso- 
lated from chicken gizzard RLC (31, 42). It can be seen that 
the RLCs expressed in smooth muscle are highly conserved 
between species. From amino acid  18 to 171, there are only 
nine differences between the chicken gizzard and rat aortic 
RLC. Of these, six are conservative substitutions. Two previ- 
ous reports  (31,  42) have presented differing sequences  for 
the first 17 amino acids of the chicken gizzard RLC. The se- 
quence  derived  from  the  rat  RLC  eDNA  is  generally  in 
agreement  with  the  sequence  published  by  Pearson  et  al. 
(42),  showing one amino acid substitution  in the rat.  How- 
ever, by rearranging the tryptic peptides designated by Maita 
et al.  (31) as T3-T7, all three sequences can be shown to be 
in good agreement. It is this rearranged chicken gizzard se- 
quence that is shown in Fig.  1 c. 
As demonstrated in Fig.  1 c, there are a number of areas 
that are highly conserved among the three rat RLCs. These 
same regions  are also  conserved  among the chicken  RLC 
2.  This sequence data have been submitted to the EMBL/GenBank Data 
Libraries under the accession number Y00622. 
a 
(Ec~ R  I)  NC~II ~sal 
Rsal  pS~I  (£eoR0 
I  I  SmRhC-6 
S~RLC-  1 
lco.~ 
b 
GCG  GCG  GCA  AAG  CTT  CGC  AGA  GAC  GCT  CAC  TCT  TGG  ~TC  TCG  CGG  CTG  48 
AGC  AGG  GAT  TrA  ACC  GCC  ACC  ATG  TCG  AGC  AAA AGA  GCG  AAG  ACC  AAG  96 
met  set  set  lys  arq  ala  lys  thr  lys 
ACC  ACC  AAG  AAG  CGC  CCT  CAG  CGC  GCA  ACG  TCC  AAC  GTG  2"rC  GCC  ATG  144 
thr  thr  lys  lys  arg  pro  gln  arg  ala  thr  set  ash  val  phe  ala  met 
GAC  CAG  TCC  CAG  ATC  CAG  GAG  TTC  AAA  GAG  GCC  ~TC  AAC  ATG  ATC  192 
phe  asp  gln  set  gln  ile  gln  glu  phe  lys  glu  ala  phe  ash  met  ile 
GAC  CAG  AAC  CGG  GAC  GGC  TTC  ATC  GAC  AAG  GAG  GAC  CTG  CAC  GAT  ATG  240 
asp  gln  ash  arg  asp  gly  phe  ile  asp  lys  glu  asp  ]eu  his  asp  met 
CTG  GCT  TCA ATG  GGA  AAA  AAT  CCA  ACT  GAT  GAA  TAC  CTG  GAC  GCC  ATG  288 
leu  ala  set  met  gly  lys  ash  pro  thr  asp  glu  tyr  leu  asp  ala  met 
ATG  AAT  GAG  GCC  CCG  GGC  CCC  ATC  AAT TTC  ACC  ATG 2~fC  CTC  ACC  ATG  336 
met  asn  glu  ala  pro  gly  pro  ile  ash  phe  thr  met  phe  leu  thr  met 
TTT  GGA  GAA  AAG  CTG  AAC  GGC  ACC  GAC  CCT  GAG  GAC  GTC  ATC  AGA  AAT  384 
phe  qly  glu  lys  leu  asn  gly  thr  asp  pro  glu  asp  val  ile  arg  ash 
GCC  TTC  GCT TGC  TTC  GAT  GAG  GAA  GCA  ATC  GGC  ACC  ATC  CAG  GAG  GAT  432 
ala  phe  ala  cys  phe  asp  glu  glu  ala  ile  gly  thr  ile  qln  glu  asp 
TAC  CTG  AGG  GAG  CTG  CTC  ACC  ACC  ATG  GGC  GAC  CGC  TTC  ACA  GAT GAG  480 
tyr  leu  arg  glu  leu  leu  thr  thr  met  gly  asp  arg  phe  thr  asp  glu 
GAA  GTG  GAT  GAG  CTG  TAC  AGG  GAG  GCC  CCC  ATC  GAC  AAA  AAG  GGG  AAT  528 
glu  val  asp  qlu  leu  tyr  arg  glu  ala  pro  ile  asp  lys  lys  gly  ash 
TTC  AAC  TAC  ATC  GAG  ~'rc  ACG  CGC  ATC  CTC  AAG  CAC  GGA  GCG  AAA  GAC  576 
phe  ash  tyr  ile  glu  phe  thr  arg  ile  leu  lys  his  gly  ala  lys  asp 
AAA  GAT  GAC  TGA  AGA  GCT  GTG  GCT  TCC  AGC  CAA  ATG  TCC  CTG  2"TG CCA  624 
lys  asp  asp 
TTG  GGT  ATT  TCT GAG  ATT  TTC  CTC  CTG  GAG  CGG  TCG  GCT  GCC  CTT  GCT  672 
T~  CTG  CCT ~  GCT  TCC  C~  G~  TTG TAT  TTA ~C  TCA  GCC  ACT TTG  720 
GGC  CAC  GTG  TAC  C~  CAT  CAT  CAG  ACT  GGA AAC  GGG  ACT  TTC  TGT  CAT  768 
TGT  TCG  ATG  AGA  ACG  TAA  GGT  AAT  TTA  ACT  TAC  AGA  CAG  TCT  TGT  CCC  816 
%~fG  TAA  TAA  CTG  CAG  CCA  CAG  AGT  CAG  TAT A~T  T~T  TCA  GAG  AAA  G~'r  864 
ATC  CAC  TCA ATT2"rTTCT  GAA  TGA  TAA  2~CAAAC  ~  CTG  ATA  AAA  TAA  912 
AAA  AAA  AAA  AAA  AAA  927 
C 
RASM  SSKRAKTKTTKKRPQ*RATSNVFAMFDQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASM 
CGSM  ......  A  ........ *  ............................................. 
RCM  *****SP-KA---LE*GGS ....  S--E-T  ......... TIM  ....  A  .....  N--R-TF-AL 
RSM  *****AP-KA-R-AAAEGS ....  S  ....  T  .........  TV  ....... I  ......  R-TF-A- 
60 
RASM  GK*NPTDEYLDAMMNEAPGPINFTMFLTMFGEKLNGTDPEDVIRNAFACFDEEAIGTIQED 
CGSM  --*  .......  EG--S  ......................................  S-F-H-- 
RCM  -RV-VKN-EI-E-IK .........  V  .....  R---K-AG--ETLL---KV-APRRRI-GA*- 
RSM  -RL-VKN-E  .....  K--S  ......  V  ......... K-A  ......  TG--KVL-P-GK---KKQ 
120 
RASM  YLRELLTTMGDRFTDEEVDELYREAPI  DKKGNFNYI E  FTRI  LKHGAKDKDD  171 
CGSM  H  ................... M  .............. V  ............... 
RCM  CVQ-M-  --QAE-  -$K--T-QMFAAF- PNVT-  ~  LD-  KNLVH-  I T--EEKD  *  * 
RSM  F-E  .....  QC---SQ-- I  KNMWAAF-P-VG--VD-KNI  CYVIT--DAKDQE 
Figure 1.  Partial restriction maps (a) of eDNA clones SmRLC-1, 
SmRLC-2, and SmRLC-6. The restriction sites in parenthesis rep- 
resent the linkers used for cloning of the eDNA into the Igt-ll vec- 
tor. Nucleotide and derived amino acid sequences (b) of SmRLC-2. 
The sequences are written 5' to 3' (NH2- to COOH-terminal). Un- 
derlined areas are those that correspond to the 39-mer and 21-mer 
oligonucleotides synthesized for primer extension analysis (see Fig. 
4). Amino acid sequence comparisons (c) among putative rat aortic 
smooth muscle RLC (RASM, this report), chicken gizzard smooth 
muscle RLC (CGSM,  reference 31), rat cardiac muscle MLC-2 
(RCM, reference 28), and rat skeletal muscle MLC-2 (RSM, refer- 
ence 39). The tryptic peptides designated as T3-T7  by Malta et al. 
(31), representing amino acids 5-16,  are rearranged to agree with 
the amino-terminal sequence of Pearson et al. (42). Numbering is 
based upon the RASM sequence, with the initiating  methionine ab- 
sent.  (-) Represents amino acids identical to that of the RASM 
RLC; (*) is used to denote positions where amino acids are not 
present. 
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amino- and carboxy-terminal ends,  between serine  19 and 
glutamine  137  there is 70 and 52 % homology between the 
amino acid sequence of the smooth muscle-derived RLC se- 
quence  and  those  of the  rat  skeletal  and  cardiac  muscle 
MLC-2,  respectively.  This  is also  seen on  the  nucleotide 
level, where the homologies are 71 and 65 %. As expected, 
the  serine  phosphorylated  by  MLC  kinase  (serine  19)  is 
found in all three rat RLC's. However, threonine  18,  which 
is also phosphorylated by myosin light chain kinase in chick- 
en gizzard (25),  is only present in the RLC isolated from 
RASM. 
The Gene Encoding the Putative Smooth Muscle RLC 
Is Expressed in Smooth, Cardiac, and Skeletal 
Muscle, and in Nonmuscle 1Issues 
The contractile protein genes of skeletal and cardiac muscle 
are expressed in a developmental and tissue-specific manner 
(see reference 18). Little is known about the expression of 
smooth muscle contractile protein genes. To examine the ex- 
pression of the gene encoding the RLC mRNA represented 
by the cDNA clones described here, RNA blot analyses were 
undertaken using total RNA isolated from a  variety of rat 
skeletal, cardiac, smooth, and nonmuscle tissues, as well as 
total cytoplasmic RNA  from RASM,  ~  (36),  and  3T3 
fibroblast cells. Fig. 2 depicts two typical experiments (top 
and bottom panels) in which the above RNAs were hybridized 
with the 32p-labeled  927-bp cDNA insert from SmRLC-2. 
Figure 2. Pattern  of expression of the gene encoding the RLC from 
RASM. RNA blot hybridizations using riP-labeled SmRLC-2 in- 
sert were done as described in Materials and Methods using 15 lag 
of RNA  from the  following rat  tissues:  (lane  1)  postconfluent 
RASM cultures;  (2)  fetal cardiac  muscle;  (3) adult  atrium;  (4) 
adult ventricle; (5) fetal skeletal muscle; (6) newborn skeletal mus- 
cle;  (7)  adult  skeletal  muscle  (leg);  (8)  adult  skeletal  muscle 
(soleus); (9) 313 fibroblasts; (10) brain; (11) liver; (12) esophagus; 
(13) placenta; (14) uterus; (15) postconfluent RASM cultures; (16) 
lung; and (17) L6E9 myoblasts. The relative mobilities of the major 
hybridizing species were calculated based on the mobilities of 28 
and  18 S ribosomal RNA and are indicated. 
Figure 3. The effect of RASM 
cell density on the expression 
of the gene encoding the RLC 
from RASM.  RNA  blot  hy- 
bridizations  using riP-labeled 
SmRLC-2  insert  were  done 
as described in Materials and 
Methods using  15 lag of cyto- 
plasmic RNA from cultures of 
RASM (passage  10)  at  (lane 
1) 50;  (2) 75;  (3)  and  100% 
confluence; and (4) 2-d post- 
confluence. Lane 5 contained 
15  lag of total RNA from rat 
aortic  tissue. 
Filters were washed at high stringency (0.1x SSC, 0.1% SDS 
at 65°C).  A  hybridizing species migrating at ~13 S can be 
observed in all tissues tested with the exception of rat liver. 
This species has the expected size for the putative smooth 
muscle  RLC.  A  second  and  weaker  hybridizing  species 
migrating at  ~11  S  can be identified  in  many RNAs.  Al- 
though its identity is not known,  its size is appropriate for 
either skeletal or cardiac muscle MLC-2 or the 17-kd smooth 
muscle MLC. It should also be noted that the  11  S species 
present in smooth muscle is slightly smaller than that seen 
in skeletal or cardiac muscle, suggesting that they do not rep- 
resent the same RNA.  The level of expression of the  13 S 
species varies markedly in different tissues and is as high or 
higher in some skeletal and nonmuscle tissues as in smooth 
muscle. Of particular interest is the high level of expression 
in the  3T3  fibroblast and L6E9 cell lines,  neither of which 
are smooth muscle cells.  Thus, the presence of high levels 
of the 13 S species is not dependent upon the existence of the 
smooth muscle contractile phenotype. 
It has  been  recently  demonstrated  that  nonmuscle  iso- 
form(s) of the myosin heavy chain (26,  44) and a-actin (41) 
predominate in subconfluent or newly confluent cultures of 
vascular smooth muscle cells, while smooth muscle isoforms 
are found primarily in postconfluent cultures.  Fig.  3 repre- 
sents a blot hybridization using 10 ktg of RNA isolated from 
RASM at varying cell densities and from intact aorta. Simi- 
lar  levels of hybridization  were  seen  in  subconfluent  and 
newly confluent cells and in intact aorta, while postconfluent 
cells contained much larger amounts of hybridizing RNA. 
Thus, induction at postconfluency of the RLC mRNA repre- 
sented by the cDNA clones described here is similar to that 
described  for  other  smooth  muscle  contractile  proteins. 
Nevertheless, as shown here for RLC, there is a significant 
amount of hybridizing  RNA present even in  subconfluent 
cultures. There appears to be no significant differences in the 
amount  of hybridizing  RNA  found  in  postconfluent  cells 
taken from the 7th through 22nd passages. 
The  RNA  blot  and  sequence  analyses  suggest  that  the 
RNA represented by the RLC cDNA clones isolated from 
smooth muscle is indeed coding for the smooth muscle RLC. 
However, the fact that this mRNA appears to be expressed 
in a wide variety of muscle and nonmuscle tissues is an unex- 
pected finding. To further examine this phenomenon and to 
get a better understanding  of the nature of the hybridizing 
species seen on the  RNA blots,  S1  nuclease mapping was 
performed using RNA from the same tissues and cells as de- 
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analysis of RLC cDNA isolated 
from RASM. 25 Ixg of RNA and 
75 U of S1 nuclease were used per 
assay.  Fragments  derived  from 
cDNA  clones  SmRLC-2  and 
SmRLC-6 were prepared as de- 
scribed  in  Materials  and  Meth- 
ods.  (a) 5% polyacrylamide gel 
of digests  using the  5'-end Pst 
I/Nco I fragment and the follow- 
ing  rat  RNAs: (lane  1)  adult 
cardiac muscle; (2) neonatal skel- 
etal muscle; (3) adult skeletal mus- 
cle (leg); (4) L6E9  myotubes; (5) 
L6E9 myoblasts; (6)  3T3  fibro- 
blasts; (7) 90% confluent RASM cultures; and (8) tRNA. The intact Pst I/Nco I probe is shown in lane 9. (b) 8% polyacrylamide gel 
of  digests using the 3'-end Rsa I fragment. Molecular weight markers are shown on the extreme left. (Lane 1 ) Intact Rsa I probe; (2) tRNA; 
(3) L6E9 myotubes; (4) adult cardiac muscle; (5) adult skeletal muscle (leg); (6) uterus; (7) 90% confluent RASM cultures; (8) brain; 
and (9) liver. It should be noted that a signal can be seen with brain RNA when the autoradiogram is exposed for longer periods of time, 
but none is detected with liver. 
scribed above. 32p-labeled probes were constructed from re- 
striction fragments of SmRLC-2 and SmRLC-6 as described 
in the Materials and Methods section. The Pst I/Nco I frag- 
ment (Fig. 4 a) was comprised of 30 nucleotides of the M13 
polylinker, the entire 5'-untranslated region and the first 386 
nucleotides of the coding region. The Rsa I fragment (Fig. 
4 b) was comprised of the final 89 nucleotides of the coding 
region and  145 nucleotides of 3'-untranslated cDNA.  With 
the exception of rat liver, all cardiac, skeletal, smooth, and 
nonmuscle tissues tested contained RNA that fully protected 
both the 3'- (234 bp) and 5'- (485 bp) end probes. It should 
be noted that the 5'-end Pst I/Nco I probe is larger than the 
"fully-protected" species seen in Fig. 4 a because it contains 
a  30-nucleotide  stretch  of  the  M13  polylinker  which  is 
cleaved by S1 nuclease after hybridization with homologous 
RNA. The S1 nuclease mapping demonstrates the presence 
of RNA homologous to the RASM RLC cDNA in cardiac, 
skeletal, and nonmuscle tissues.  This result, together with 
the RNA blot data, supports the conclusion that the expres- 
sion of the putative smooth muscle RLC gene(s) is ubiqui- 
tous. Aside from the fully protected fragments, partially pro- 
tected fragments are produced by hybridization of the Pst 
I/Nco I probe to most of the RNAs tested (Fig.  4  a). The 
identity of these fragments is not known. It is possible that 
they result from partial S1 nuclease digestion, although this 
interpretation is unlikely since the same banding pattern is 
seen at high enzyme concentrations.  Whether these addi- 
tional RNAs represent the products of other MLC genes or 
are the products of differential splicing has not yet been elu- 
cidated. 
It may be noted that the cardiac and skeletal muscle tissues 
produced bands of greater intensity than that seen for RASM 
in the S1  mapping experiments while the reverse appeared 
true in the RNA blot hybridizations. This is due in large part 
to differences in the RNA used for each type of experiment. 
In particular, the RASM RNA used in the blot hybridizations 
was isolated from cultures that were postconfluent and thus 
as noted in Fig. 3 contained large amounts of the RLC RNA 
while that used for the S1 mapping was isolated from 90% 
confluent cultures and thus contained smaller amounts. Sim- 
ilarly,  different preparations  of skeletal  and  cardiac  mus- 
cle were used for the blot hybridizations and  S1  nuclease 
analyses. 
RLC mRNA's Expressed in Muscle and Nonmuscle 
Cells Are Transcribed from the Same Promoter Region 
The finding that RNA homologous to the RLC cDNA was 
present in sarcomeric, smooth muscle, and nonmuscle tis- 
sues was unexpected. To determine whether this RNA was 
derived from the same promoter(s) or from different pro- 
moters specific to each cell type, primer extension analysis 
was  performed. A  21-mer oligonucleotide was  synthesized 
that corresponded to nucleotides 181-201 of the noncoding 
strand of SmRLC-2 (Fig. 1 b, underlined region). This probe 
was used for primer extension after hybridization to 25 ~tg 
of RASM,  L6Eg, and 3T3  RNA.  Elongated products were 
examined on 6% acrylamide sequencing gels. As shown in 
Fig. 5, two species of ~194 and 218 nucleotides were seen 
in all three cultures tested. Similar results were found with 
all three cultures using a  39-mer corresponding to nucleo- 
tides 35-73 (Fig.  1 b, underlined region; results not shown). 
As described in the previous section, the S1 nuclease map- 
ping experiments showed that all three cell types contained 
RNAs  that  fully protected the  5'-end  cDNA  probe.  This 
probe contained the entire 5'-untranslated region and there- 
fore included the entire sequence comprising the  smaller 
(194 nucleotide) primer extension product and all but the last 
17 nucleotides of the larger (218 nucleotide) product. While 
it is possible that there is sequence divergence in those  17 
nucleotides and that the identical sizes of the larger extension 
products among the three cell types tested are coincidental, 
taken in concert with the results of the SI nuclease mapping 
experiments, the most likely explanation for the results of the 
primer extension analyses are that the same RLC message 
is produced in all three cell types and that this message de- 
rives from the same promoter in RASM, 3T3 fibroblasts, and 
L6F_,9 myoblasts. The shorter primer extension product like- 
ly represents a point of premature termination of the reac- 
tion, but the possibility that it represents an additional start 
site(s) has not been formally excluded. In fact, heterogeneity 
Taubman et al. Mammalian Myosin Smooth Muscle Regulatory Light Chain  1509 Figure 5. Primer extension analysis of the RLC 5' cDNA sequences 
using RNA from sarcomeric, smooth, and nonmuscle cells. A 21-mer 
oligonucleotide (see Fig.  1 b for its location on the RLC cDNA) 
was synthesized as described in Materials and Methods, hybridized 
to cytoplasmic RNA from L6F_,9 myotubes (lane 2), RASM cells 
(lane 3), and 3T3 fibroblasts (lane 4), and extended with reverse 
transcriptase. Extended products were analyzed on a 6% polyacryl- 
amide-urea  gel  along  with  molecular  weight  markers  (lane  1). 
Molecular weights of  the two initiation sites are noted by arrows and 
were calculated  from their  relative positions  with respect  to the 
markers. 
in the transcription start site is a common feature of house- 
keeping promoters. The length of the longer primer exten- 
sion product suggests that most of the 5'-untranslated region 
is contained within clone SmRLC-2. Since that clone also 
contains a small poly-A tail, SmRLC-2 represents a virtual 
full length transcript of the RLC mRNA. Sequencing of the 
primer extension product was not possible due to the small 
amount of extended DNA produced. However, analysis of rat 
genomic  clones  recently  isolated  by  hybridization  with 
SmRLC-2 cDNA should allow for further elucidation of the 
5' end. 
Discussion 
We report the isolation of cDNA clones encoding the 20-kD 
smooth muscle RLC. Clone SmRLC-2 is a near full-length 
transcript of the RLC mRNA, containing 5'- and 3'-untrans- 
lated regions of 69 and 342 nucleotides, respectively. The de- 
rived amino acid sequence of the coding region shows strik- 
ing homology with that of the chicken gizzard RLC, with 
only 10 substitutions out of 171 amino acids, suggesting that 
the cDNA encodes a  smooth muscle RLC isoform. 
Work  from  several  laboratories  has  demonstrated  that 
there are a number of myosin heavy chain isoforms expressed 
in  cultured  smooth muscle cells  (26,  29,  44).  Nonmuscle 
myosin heavy chain appears to be the predominant species 
present in subconfluent and newly confluent cultures, where- 
as significant amounts of smooth muscle isoform(s) are pres- 
ent only in postconfluent cultures. Similar induction of smooth 
muscle actin isoforms has been seen in postconfluent RASM 
cultures (41). Unlike these instances, where multiple isoforms 
are known to exist in  culture,  only a  single RLC isoform 
has been detected in RASM (19). One possible explanation 
is that only a smooth muscle RLC isoform is present in adult 
RASM and a separate nonmuscle isoform is present in non- 
muscle cells. A second explanation is that both smooth and 
nonmuscle isoforms are present in RASM but are so similar 
in sequence that they cannot be resolved by gel electrophore- 
sis or immunoprecipitation. A third possibility, which we fa- 
vor,  is  that  the  smooth  muscle and  nonmuscle  RLC's are 
identical  and  are  encoded  either  by the  same gene or by 
different  genes  containing  identical  coding  regions.  The 
RLC encoded by the cDNA clones described in this study 
has striking sequence homology to the chicken gizzard RLC 
and thus likely represents a  smooth muscle isoform. How- 
ever, the lack of available nonmuscle RLC sequence prevents 
us from formally proving this point.  Accordingly, we refer 
to the clone as a  "putative" smooth muscle RLC. 
The conservation of primary structure between the chick- 
en gizzard RLC and the putative rat smooth muscle RLC 
(94.2%) is somewhat higher than that reported for species 
differences among the  light chains  of cardiac  and  skeletal 
muscle. This may reflect the importance of the primary struc- 
ture in providing the  smooth muscle RLC with its unique 
properties in regulating both actin-activated myosin ATPase 
activity and smooth muscle contraction.  In contrast,  there 
are significant differences between the derived amino acid 
sequences of the putative rat smooth muscle RLC and that 
of rat skeletal and cardiac muscle MLC-2. The most striking 
differences are found at both the amino and carboxy termini. 
Kemp et al. (27) have reported that the sequence at the amino 
terminus of the chicken smooth muscle RLC is critical to the 
activity of the smooth muscle MLC kinase on the RLC.  It 
would  thus  not be surprising  that this area is highly  con- 
served between the rat and chicken smooth muscle RLCs. In 
contrast, the differences in this region between smooth and 
sarcomeric muscle RLCs might provide a means by which 
the light chains can be distinguished by their respective ki- 
nases.  The role of the carboxy terminus in smooth muscle 
RLC function is unclear. Here again, the level of conserva- 
tion between chicken and rat is in distinct contrast to the al- 
most total lack of amino acid sequence homology between 
the putative rat smooth muscle RLC and the  RLCs of rat 
skeletal and cardiac muscle. This raises the question as to 
whether the structure of the carboxy terminus is important 
in providing the smooth muscle RLC with its differentiated 
functions.  Despite the differences between  the  sarcomeric 
and smooth muscle RLCs at the carboxy and amino termini, 
there are a number of areas (amino acids 19-53 and 75-99) 
where the  sequences  are highly  conserved (>75 %  homol- 
ogy).  This  argues  strongly  that  the  gene(s)  encoding  the 
putative smooth muscle RLC originated by duplication of the 
same ancestor that gave rise to the MLC-2 genes. 
The expression of the putative smooth muscle RLC was 
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ping. It has been shown that the RNA encoding the putative 
smooth muscle RLC is present not only in smooth muscle, 
but in cardiac, skeletal, and nonmuscle cells and tissues as 
well.  This result is unexpected.  Studies of adult and em- 
bryonic cardiac and skeletal muscle using two-dimensional 
gel electrophoresis have failed to disclose the presence of 
smooth muscle RLC protein in chicken sarcomeric tissues 
at any stage of development (54),  although a 20-kD MLC 
electrophoretically distinct from skeletal muscle MLCs was 
demonstrated in "presumptive" myoblast cells (11, 12). The 
presence of smooth muscle RLC protein in rat sarcomeric 
tissues has not been demonstrated. 
One possible explanation for our findings would be the 
presence of contaminating vascular smooth muscle in the tis- 
sues used to prepare the RNA.  The amount of such con- 
taminating material is relatively small and unlikely to give 
a signal of equal or greater strength than seen in tissues de- 
rived directly from smooth muscle.  More importantly, the 
lack of a signal in several different preparations of rat liver, 
a highly vascular organ, strongly argues against contamina- 
tion from blood vessels as being a source of the smooth mus- 
cle RNA in skeletal or cardiac tissues. The lack of hybridiz- 
ing RNA in rat liver is itself intriguing, as it is the only tissue 
in which this has been the case.  Similar results have been 
noted using a  smooth muscle ct-tropomyosin cDNA probe 
(Wieczorek, D. E, and B. Nadal-Ginard, manuscript in prep- 
aration),  which hybridizes with all tissues except rat liver. 
These liver preparations do give appropriate signals when 
hybridized to nonmuscle probes. The presence of hybridiz- 
ing RNA in cloned lines such as 3T3  fibroblast and L6E9 
myoblasts further argues against contaminating smooth mus- 
cle elements being responsible for the signals seen in non- 
smooth muscle tissues. As noted earlier, a second explana- 
tion for the ubiquitous presence of homologous RNA is that 
the cDNA isolated in this report either encodes the nonmus- 
cle myosin RLC or that the nonmuscle and smooth muscle 
RLCs are products of the same gene or of genes with strik- 
ingly similar coding regions. 
Both RNA blot analysis and S1 nuclease mapping suggest 
that the amount of putative smooth muscle RLC  RNA is 
equal or greater in some sarcomeric tissues than that seen 
in smooth muscle tissues or cells. Were the RNAs to be trans- 
lated  with  equal  efficiency in  all  tissues,  it would  be ex- 
tremely likely that the protein corresponding to the 20-kD 
RLC would be found in sarcomeric tissues. Nevertheless, as 
mentioned above,  20-kD  MLCs  similar  to either smooth 
muscle or nonmuscle RLC have been found in presumptive 
myoblasts but not in other skeletal or cardiac tissues to any 
significant degree. It thus appears likely that the regulation 
of smooth  muscle  RLC  synthesis  is  a  posttranscriptional 
event. In sarcomeric tissues, the RNA is expressed in high 
levels like those of the other contractile proteins (and in the 
case of L6E9 cells is expressed in even greater amounts in 
myotubes  than  in  myoblasts),  but  is  not  translated  into 
significant amounts of stable RLC protein. In smooth mus- 
cle, the RNA is expressed at lower levels, but is translated 
into  readily  detectable  RLC  protein.  Thus,  the  putative 
smooth muscle RLC gene(s) appears to be constitutively ex- 
pressed in a large variety of cells shows neither significant 
tissue or developmental specificity, but has a differentiated 
function in smooth muscle cells. 
There is limited information concerning the expression of 
smooth muscle contractile protein genes, a-Tropomyosin has 
been shown to be encoded by a single gene that is spliced al- 
ternatively to produce smooth, skeletal, and cardiac muscle 
forms (45) which are expressed uniquely in the correspond- 
ing tissues. As mentioned earlier, a variety of actin forms, 
including both smooth muscle-specific and nonmuscle ac- 
tins, has been found in several smooth muscle tissues (20, 
57).  These are expressed in a  tissue-specific manner and 
changes in expression are seen concomitant with changes in 
smooth muscle cell phenotype (19, 20, 41). The smooth mus- 
cle myosin heavy chain has yet to be well characterized and 
the number of smooth muscle heavy chain genes is unknown. 
However, it is clear that the smooth muscle myosin heavy 
chain(s)  is  antigenically (58)  and genetically (37)  distinct 
from that of skeletal or cardiac muscle. The work presented 
in this report demonstrates that the putative smooth muscle 
RLC is expressed not only in smooth muscle, but in sarco- 
meric muscle and in nonmuscle tissues as well. Thus, its ex- 
pression appears to be distinct from the expression of other 
vertebrate muscle contractile proteins and together with the 
23-kD embryonic light chain expressed in chicken smooth, 
cardiac, and skeletal muscle is the only known muscle con- 
tractile protein gene to be expressed in all types of muscle 
cells. In this regard, the expression of the putative smooth 
muscle RLC may represent an earlier stage in the evolution 
of contractile protein gene regulation:  the smooth muscle 
RLC being transcribed in most cell types, but translated only 
in some cells, and the sarcomeric RLC being transcribed 
only in sarcomeric tissues. 
The smooth muscle cell expresses both contractile and 
noncontractile phenotypes, which are both distinct and re- 
versible (see reference 10). Changes in phenotype are seen 
not only in cell culture, but also in areas of atherosclerotic 
plaques and blood vessel injury. An important feature of this 
so-called "phenotypic modulation" is a change in the number 
and in the staining patterns of myosin-containing thick fila- 
ments  (see reference 10) and in the expression of smooth 
muscle actins (20,  41).  One hypothesis for this phenotypic 
modulation is that there is coordinate regulation on the tran- 
scriptional level of specific smooth muscle contractile pro- 
tein genes, resulting in either a contractile or noncontractile 
phenotype. The finding that the putative smooth muscle RLC 
gene appears to be constitutively expressed in most cells sug- 
gests that the regulation of the contractile phenotype may re- 
quire more than transcriptional regulation and may involve 
posttranscriptional or translational events as well. The recent 
availability of cDNA probes, not only for the RLC but for 
other smooth  muscle contractile proteins as  well,  should 
provide a valuable tool for elucidating the molecular regula- 
tion of smooth muscle cell contraction. 
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